Product

ATL1102

Aliases

ATL1102 25mg, ATL1102 50mg

1 clinical trial

1 indication

Indication

Duchenne muscular dystrophy

Clinical trial

A Multicentre, Randomised, Double-blind, Placebo-controlled and Open Label Extension Study to Assess the Efficacy, Safety, and Pharmacokinetic Profile of of ATL1102 in Non-ambulatory Participants With Duchenne Muscular Dystrophy

Status: Recruiting, Estimated PCD: 2024-11-13